Page last updated: 2024-08-17

quinoxalines and Adenoma, Prolactin-Secreting, Pituitary

quinoxalines has been researched along with Adenoma, Prolactin-Secreting, Pituitary in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, Y; Cheng, X; Wang, S; Wang, X; Wu, J; Zhang, H; Zhang, Y; Zhu, K	1

Other Studies

1 other study(ies) available for quinoxalines and Adenoma, Prolactin-Secreting, Pituitary

Article	Year
PBK/TOPK Inhibitor Suppresses the Progression of Prolactinomas. Frontiers in endocrinology, 2021, Volume: 12 Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Databases, Genetic; Estrogens; Gene Expression Profiling; Gene Regulatory Networks; Humans; In Vitro Techniques; Indolizines; Mitogen-Activated Protein Kinase Kinases; Molecular Targeted Therapy; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pituitary Neoplasms; Prolactin; Prolactinoma; Protein Interaction Maps; Quinoxalines; Rats	2021

Article

Year

PBK/TOPK Inhibitor Suppresses the Progression of Prolactinomas.

Frontiers in endocrinology, 2021, Volume: 12

Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Databases, Genetic; Estrogens; Gene Expression Profiling; Gene Regulatory Networks; Humans; In Vitro Techniques; Indolizines; Mitogen-Activated Protein Kinase Kinases; Molecular Targeted Therapy; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pituitary Neoplasms; Prolactin; Prolactinoma; Protein Interaction Maps; Quinoxalines; Rats

2021